在血造干细胞移植后复发的急性髓性白血病的治疗选择
Alkim Yolcu1, Elifcan Aladag Karakulak1, Hakan Goker1
1Division of Hematology/Bone Marrow Transplantation, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Expert review of hematology
|August 13, 2025
概括
在异性造血干细胞移植 (allo-HCT) 后复发的急性髓性白血病 (AML) 构成了重大挑战. 目前正在探索治疗策略,以改善移植后AML复发的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 干细胞移植 干细胞移植
背景情况:
- 急性髓性白血病 (AML) 是一种骨髓衰竭疾病.
- 全源性造血干细胞移植 (allo-HCT) 为AML提供治疗潜力.
- 复发后的HCT是一种主要的死亡原因,具有具有挑战性的治疗模式.
研究的目的:
- 审查当前的AML复发的治疗选择,在Allo-HCT后.
- 为在移植后复发的AML中提供最佳治疗选择的框架.
- 强调需要标准化和个性化的治疗方法.
主要方法:
- 在PubMed.com上搜索到2025年3月的文献.
- 关键词:复发性AML,全源造血干细胞移植,治疗选择.
- 审查现有的治疗策略和临床试验数据.
主要成果:
- 目前没有标准化治疗方法存在复发的AML后合HCT.
- 包括化疗,向药物和免疫疗法在内的组合疗法显示出有前途.
- 个性化治疗模式往往是必要的.
结论:
- 改善复发性AML的应答率和存活率需要新的策略.
- 进一步的研究对于降低复发风险和开发有效的组合疗法至关重要.
- 个性化治疗和探索新组合是提高疗效的关键.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


